Legend Biotech Corporation (LEGN)
USD 31.25
(-4.96%)
USD 31.25
(-4.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -949.39 Million USD | -89.31% |
| 2022 | -501.49 Million USD | 11.39% |
| 2021 | -565.97 Million USD | -25.13% |
| 2020 | -452.31 Million USD | -485.3% |
| 2019 | -77.27 Million USD | 62.46% |
| 2018 | -205.84 Million USD | -11051.08% |
| 2017 | -1.84 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -563.24 Million USD | 40.67% |
| 2024 Q2 | 137.24 Million USD | 124.37% |
| 2023 Q1 | -345.28 Million USD | 31.15% |
| 2023 Q4 | -949.39 Million USD | -47.66% |
| 2023 Q2 | -914.59 Million USD | -164.88% |
| 2023 FY | -949.39 Million USD | -89.31% |
| 2023 Q3 | -642.96 Million USD | 29.7% |
| 2022 Q1 | -248.55 Million USD | 56.08% |
| 2022 Q4 | -501.49 Million USD | 36.2% |
| 2022 Q3 | -786.03 Million USD | -327.06% |
| 2022 FY | -501.49 Million USD | 11.39% |
| 2022 Q2 | -184.05 Million USD | 25.95% |
| 2021 Q1 | -409.16 Million USD | 9.54% |
| 2021 FY | -565.97 Million USD | -25.13% |
| 2021 Q4 | -565.97 Million USD | -113.73% |
| 2021 Q3 | -264.81 Million USD | 43.43% |
| 2021 Q2 | -468.1 Million USD | -14.41% |
| 2020 Q4 | -452.31 Million USD | -1.55% |
| 2020 FY | -452.31 Million USD | -485.3% |
| 2020 Q2 | -558.95 Million USD | -240.74% |
| 2020 Q1 | -164.04 Million USD | -112.27% |
| 2020 Q3 | -445.39 Million USD | 20.32% |
| 2019 Q1 | 216.18 Million USD | 0.0% |
| 2019 FY | -77.27 Million USD | 62.46% |
| 2019 Q4 | -77.27 Million USD | 0.0% |
| 2018 FY | -205.84 Million USD | -11051.08% |
| 2017 FY | -1.84 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -1597.172% |
| Alkermes plc | -166.73 Million USD | -469.392% |
| Agenus Inc. | 274.13 Million USD | 446.324% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 150.772% |
| Aptorum Group Limited | 1.35 Million USD | 70060.635% |
| Ardelyx, Inc. | 34.51 Million USD | 2850.921% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 22282.196% |
| Bicycle Therapeutics plc | -481.46 Million USD | -97.189% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 2725.33% |
| ChromaDex Corporation | -24.04 Million USD | -3847.929% |
| Chimerix, Inc. | -25.51 Million USD | -3620.649% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 13724.966% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -3909.79% |
| CRISPR Therapeutics AG | -150.84 Million USD | -529.386% |
| Precision BioSciences, Inc. | -85.41 Million USD | -1011.577% |
| Dyadic International, Inc. | -6.37 Million USD | -14785.282% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -5858.69% |
| Fortress Biotech, Inc. | 7.66 Million USD | 12486.145% |
| Lantern Pharma Inc. | -21.7 Million USD | -4274.445% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -758.896% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -11012.94% |
| Incyte Corporation | -3.17 Billion USD | 70.099% |
| IO Biotech, Inc. | -140.69 Million USD | -574.772% |
| Jaguar Health, Inc. | 29.39 Million USD | 3330.234% |
| Novavax, Inc. | -298.29 Million USD | -218.276% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 17888.983% |
| Opthea Limited | 28.15 Million USD | 3471.748% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -5554.881% |
| ContextLogic Inc. | -232 Million USD | -309.223% |
| MiMedx Group, Inc. | -33.9 Million USD | -2700.501% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 9412.388% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -40874.835% |
| NextCure, Inc. | -6.47 Million USD | -14557.99% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -1779.959% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -14783.179% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 7905.452% |
| Vaxcyte, Inc. | -368.22 Million USD | -157.83% |
| PDS Biotechnology Corporation | -32.7 Million USD | -2802.568% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 5594.837% |
| Pharming Group N.V. | 109.8 Million USD | 964.63% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -5357.565% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -441.801% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -5026.379% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -5026.379% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -13271.803% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -16101.331% |
| Acelyrin, Inc. | -216.9 Million USD | -337.706% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -16822.51% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -54969.49% |
| Summit Therapeutics Inc. | 34.67 Million USD | 2838.069% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -13855.578% |
| Senti Biosciences, Inc. | 1.74 Million USD | 54663.103% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -414.281% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -1125.805% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -15561.465% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 951696.187% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 151278.025% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -711.132% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -464.335% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 956.316% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -12398.657% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -635.318% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 13870.172% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -291.726% |
| Immix Biopharma, Inc. | -17.5 Million USD | -5322.098% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -199.775% |
| MEI Pharma, Inc. | -3.7 Million USD | -25524.777% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 7688.506% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 686.983% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 3515.961% |
| Fortress Biotech, Inc. | 7.66 Million USD | 12486.145% |
| Precigen, Inc. | -481 Thousand USD | -197280.042% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 6842.405% |
| AlloVir, Inc. | -62.69 Million USD | -1414.385% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -1607.121% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 1639.581% |
| ImmuCell Corporation | 10.99 Million USD | 8738.303% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -515.908% |
| Onconetix, Inc. | 5.33 Million USD | 17907.544% |
| PureTech Health plc | -167.19 Million USD | -467.832% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -3016.868% |
| Elevation Oncology, Inc. | -19.11 Million USD | -4865.99% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -19239.947% |
| Seer, Inc. | -4.24 Million USD | -22291.462% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -3849.736% |
| Innoviva, Inc. | 255.56 Million USD | 471.493% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -1599.481% |
| ESSA Pharma Inc. | -33.62 Million USD | -2723.775% |
| GlycoMimetics, Inc. | -40.98 Million USD | -2216.485% |
| GT Biopharma, Inc. | -1.02 Million USD | -92887.071% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -1300.643% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 1649.86% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -608.089% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -6751.891% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -3188.3% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -1260151.679% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -2976.269% |
| Aptose Biosciences Inc. | -8.19 Million USD | -11485.291% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -30241.724% |
| Soligenix, Inc. | -4.95 Million USD | -19073.572% |
| Century Therapeutics, Inc. | 847 Thousand USD | 112189.492% |
| Kura Oncology, Inc. | -20.11 Million USD | -4619.147% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -2219.792% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -11205.049% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 52216.188% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -29596.528% |
| Autolus Therapeutics plc | -186.59 Million USD | -408.791% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -1825.6% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -244.242% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 2870.509% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 677.605% |
| GRI Bio, Inc. | -1.79 Million USD | -52820.736% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -10468.776% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -2754.731% |
| IGM Biosciences, Inc. | -72.6 Million USD | -1207.603% |
| INmune Bio, Inc. | -25.41 Million USD | -3636.169% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 728.944% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1774.095% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -5742.675% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -32808.92% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 2597.43% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -2205.203% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 3077.569% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 351.196% |
| Verastem, Inc. | -37.27 Million USD | -2446.805% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -10363.992% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -1730.624% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -6172.864% |
| Histogen Inc. | -7.48 Million USD | -12580.62% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -4293.974% |
| Surrozen, Inc. | -32.66 Million USD | -2806.558% |
| Organovo Holdings, Inc. | -1.5 Million USD | -62899.204% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -22485.957% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 5107.318% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 36391.972% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 22944.033% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -11227.777% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -2085.438% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -6413.049% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -199.694% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -131384.641% |
| Apollomics, Inc. | -27.39 Million USD | -3365.589% |
| Amarin Corporation plc | -191.04 Million USD | -396.963% |
| Mesoblast Limited | 55.96 Million USD | 1796.474% |
| Turnstone Biologics Corp. | -14.58 Million USD | -6409.86% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -3653.748% |
| Synaptogenix, Inc. | -28.66 Million USD | -3212.451% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -101331.41% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 2048.202% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -110027.609% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -12966.165% |
| Exelixis, Inc. | -73.05 Million USD | -1199.655% |
| Better Therapeutics, Inc. | -860 Thousand USD | -110295.116% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -3853.683% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -293.336% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 129082.727% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -12663.925% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 75809.569% |
| Gritstone bio, Inc. | 39.49 Million USD | 2504.148% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -1028.878% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -35969.434% |
| Avid Bioservices, Inc. | 169.72 Million USD | 659.364% |
| Insmed Incorporated | 721.62 Million USD | 231.565% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -10285.569% |
| MediWound Ltd. | -5.32 Million USD | -17739.121% |
| OmniAb, Inc. | 9.2 Million USD | 10416.18% |
| Alector, Inc. | -35.63 Million USD | -2564.079% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 1204.324% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -19165.381% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 7271.221% |
| Zai Lab Limited | -775 Million USD | -22.503% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 378.78% |
| Aura Biosciences, Inc. | -21.52 Million USD | -4310.676% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -1051.065% |
| Immunic, Inc. | -45.34 Million USD | -1993.952% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -391.369% |
| Veracyte, Inc. | -203.82 Million USD | -365.793% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 248.74% |
| FibroGen, Inc. | 56.76 Million USD | 1772.447% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 10761.404% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -33482.259% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -45756.928% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 120.683% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -28316.582% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -472.051% |
| TG Therapeutics, Inc. | 17.86 Million USD | 5415.183% |
| Galecto, Inc. | -21.21 Million USD | -4374.915% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -3891.583% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 160.494% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -3779.528% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -8150.613% |
| XBiotech Inc. | -200.02 Million USD | -374.644% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -1028.878% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 21067.27% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -2592.335% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -1129.503% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 16782.446% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -457.109% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -927.776% |
| Vaxxinity, Inc. | 10.13 Million USD | 9470.292% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 228.948% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -8717.214% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -1339.441% |
| NexImmune, Inc. | -3.13 Million USD | -30196.942% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -27397.478% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -6182.64% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -3403.314% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -10477.01% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -762009.573% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -2240.033% |
| Ainos, Inc. | 4.07 Million USD | 23381.382% |
| Pluri Inc. | 22.82 Million USD | 4258.737% |
| Prothena Corporation plc | -608.34 Million USD | -56.062% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -699.453% |
| Celularity Inc. | 65.19 Million USD | 1556.355% |
| Rallybio Corporation | -24.1 Million USD | -3839.084% |
| Cue Biopharma, Inc. | -33.81 Million USD | -2707.292% |
| MeiraGTx Holdings plc | -40.3 Million USD | -2255.709% |
| Omeros Corporation | 331.17 Million USD | 386.675% |
| Humacyte, Inc. | -22.48 Million USD | -4122.174% |
| Immunocore Holdings plc | -358.59 Million USD | -164.756% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -3763.268% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -2972.386% |
| Blueprint Medicines Corporation | 702.83 Million USD | 235.081% |
| CalciMedica, Inc. | -5.53 Million USD | -17068.137% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -404.409% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -9195.066% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -2271.302% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -2755.075% |
| Pulmatrix, Inc. | -10.41 Million USD | -9013.929% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -15784.189% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -2389.114% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -752.227% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -1483.808% |
| Cytokinetics, Incorporated | 642.37 Million USD | 247.796% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -16204.276% |
| Nutriband Inc. | -251.65 Thousand USD | -377158.729% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -2682.608% |
| Vor Biopharma Inc. | 4.3 Million USD | 22179.023% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 84.271% |
| Evogene Ltd. | -19.63 Million USD | -4735.479% |
| ProKidney Corp. | -56.23 Million USD | -1588.239% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -1850.604% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -10177.999% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 169.609% |
| CorMedix Inc. | -43.05 Million USD | -2105.21% |
| BioLineRx Ltd. | 7.33 Million USD | 13041.63% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -3356.756% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 2157.334% |
| Atai Life Sciences N.V. | -28.55 Million USD | -3224.455% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 42663.804% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -4061.106% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 5453.245% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -1164.616% |
| MediciNova, Inc. | -50.78 Million USD | -1769.5% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -1104.743% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -4220384.552% |
| GeoVax Labs, Inc. | -6.45 Million USD | -14613.443% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -375.124% |
| Biomea Fusion, Inc. | -166.57 Million USD | -469.969% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -430.464% |
| Mereo BioPharma Group plc | -51.46 Million USD | -1744.602% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -901.01% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -223.189% |
| Absci Corporation | -72.59 Million USD | -1207.747% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 20892.773% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -304.969% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -907.736% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -892.098% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -2329.806% |
| Allakos Inc. | -24.97 Million USD | -3701.393% |
| Imunon, Inc. | -4.21 Million USD | -22430.407% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -6340.09% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -601.18% |
| BioAtla, Inc. | -109.01 Million USD | -770.919% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 129082.727% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -101007.348% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 8034.13% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -4377.659% |
| XOMA Corporation | -29 Million USD | -3173.786% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -5633.08% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -10430.146% |
| aTyr Pharma, Inc. | -7.44 Million USD | -12645.308% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -661.737% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -356.082% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -1060.931% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -923.466% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -110399.963% |
| Akari Therapeutics, Plc | -3.84 Million USD | -24591.756% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 58600.453% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 168.753% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -79806.576% |
| UroGen Pharma Ltd. | 4.39 Million USD | 21721.453% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 936.614% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 1319404.633% |
| Orgenesis Inc. | 21.78 Million USD | 4458.235% |
| Entera Bio Ltd. | -10.62 Million USD | -8832.148% |
| GH Research PLC | -78.07 Million USD | -1115.977% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -4159.682% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -3461.266% |
| Xencor, Inc. | 29.64 Million USD | 3302.665% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -48097.391% |
| Replimune Group, Inc. | 1.41 Million USD | 67337.819% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -387554.956% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -651.005% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -79806.576% |
| Portage Biotech Inc. | -4.98 Million USD | -18960.389% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -4220384.552% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -1335.828% |
| OncoCyte Corporation | -6.56 Million USD | -14365.915% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 105892.762% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -20740.044% |
| Purple Biotech Ltd. | -14.13 Million USD | -6615.221% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -3896.456% |
| scPharmaceuticals Inc. | -6.54 Million USD | -14405.699% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -5587.686% |
| HilleVax, Inc. | -165.48 Million USD | -473.706% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -37307.329% |
| Tharimmune, Inc. | -10.93 Million USD | -8581.915% |
| Genprex, Inc. | -6.73 Million USD | -13990.981% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -157.424% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -973.251% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -67665.739% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -28522.655% |
| OKYO Pharma Limited | -826.84 Thousand USD | -114721.346% |
| Savara Inc. | 153 Thousand USD | 620621.569% |
| Curis, Inc. | -23.88 Million USD | -3874.538% |
| Daré Bioscience, Inc. | -5.15 Million USD | -18306.638% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -122243.211% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -15193.138% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 80217.975% |
| BeiGene, Ltd. | -2.25 Billion USD | 57.862% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 7794.598% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -56.099% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -411.568% |
| Erasca, Inc. | -37.21 Million USD | -2451.048% |
| bluebird bio, Inc. | 108.57 Million USD | 974.449% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -73617.149% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 350.667% |
| DBV Technologies S.A. | -126.98 Million USD | -647.64% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -73617.149% |
| Moderna, Inc. | -2.9 Billion USD | 67.341% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -9071.155% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -8635.72% |
| Molecular Templates, Inc. | 707 Thousand USD | 134385.431% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -2926.356% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 373.911% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -1056.928% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -934.992% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -2841.863% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -2661.805% |
| MacroGenics, Inc. | -66.98 Million USD | -1317.329% |
| RenovoRx, Inc. | -1.17 Million USD | -80837.596% |
| Adicet Bio, Inc. | -138.78 Million USD | -584.068% |
| Prime Medicine, Inc. | -27.94 Million USD | -3297.867% |
| Aditxt, Inc. | 18.12 Million USD | 5339.247% |
| Adagene Inc. | -87.62 Million USD | -983.449% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -22692.328% |
| Quantum-Si incorporated | -118.55 Million USD | -700.795% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 2736.85% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -12602.356% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -1857.158% |
| SciSparc Ltd. | -2.06 Million USD | -45875.69% |
| Vericel Corporation | 1.27 Million USD | 74445.967% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -7817.125% |
| Minerva Neurosciences, Inc. | 41 Million USD | 2415.365% |
| Generation Bio Co. | 31.44 Million USD | 3118.946% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -441.387% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -2970.2% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 914.284% |
| Invivyd, Inc. | -198.47 Million USD | -378.344% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -951.731% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -39496.39% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -1241.147% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -13810.593% |
| 2seventy bio, Inc. | 181.71 Million USD | 622.465% |
| ADMA Biologics, Inc. | 90.06 Million USD | 1154.114% |
| Clene Inc. | 3.34 Million USD | 28525.09% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -10352.813% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -4313.547% |
| GeoVax Labs, Inc. | -6.45 Million USD | -14613.443% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -175.888% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -3551.575% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 634.372% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -23103.775% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 19080.368% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -18126.109% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -628.602% |
| Evaxion Biotech A/S | 5.28 Million USD | 18057.746% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -743.4% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -623.224% |
| Trevena, Inc. | 2.25 Million USD | 42145.97% |
| Surrozen, Inc. | -32.66 Million USD | -2806.558% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -1743.133% |
| Cingulate Inc. | 3.08 Million USD | 30897.782% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -32225.434% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 13309.935% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -10118.22% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -1096.876% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -622.239% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -799.545% |
| Clearmind Medicine Inc. | -3.94 Million USD | -23980.279% |
| Kronos Bio, Inc. | -36.05 Million USD | -2533.267% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 10190.318% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 65210.789% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -1649.849% |
| Statera Biopharma, Inc. | 14.41 Million USD | 6685.539% |
| ImmunityBio, Inc. | 618.22 Million USD | 253.569% |
| Korro Bio, Inc. | -132.94 Million USD | -614.139% |
| Kineta, Inc. | -4.54 Million USD | -20807.245% |
| BioVie Inc. | -17.73 Million USD | -5254.045% |
| Codexis, Inc. | -43.27 Million USD | -2094.075% |
| Celularity Inc. | 65.19 Million USD | 1556.355% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -29858.914% |
| Celcuity Inc. | 6.78 Million USD | 14095.677% |
| Virax Biolabs Group Limited | -3.36 Million USD | -28114.377% |
| Cibus, Inc. | -8.07 Million USD | -11652.884% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -22349.704% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 20874.573% |
| IN8bio, Inc. | -16.38 Million USD | -5692.898% |
| Kodiak Sciences Inc. | -103.87 Million USD | -813.981% |
| Annexon, Inc. | -193.75 Million USD | -389.999% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 2637316.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -5325.441% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -26925.278% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 190.052% |
| Eyenovia, Inc. | 1.25 Million USD | 75526.749% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 3628.705% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -29175.301% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -2755.59% |
| Arcellx, Inc. | -296.95 Million USD | -219.708% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -4767.21% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -1512.566% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -4480.489% |
| Moolec Science SA | 117.61 Thousand USD | 807301.401% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -2372.455% |
| Geron Corporation | 14.76 Million USD | 6531.8% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -2403.819% |
| Royalty Pharma plc | 5.65 Billion USD | 116.779% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -571.327% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -13483.351% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -17603.206% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -574.619% |
| Humacyte, Inc. | -22.48 Million USD | -4122.174% |
| Structure Therapeutics Inc. | -124.33 Million USD | -663.556% |
| 89bio, Inc. | -289.05 Million USD | -228.451% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -3661.184% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -53147.224% |
| Genelux Corporation | -6.89 Million USD | -13661.386% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -2956.756% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 1235.657% |
| Notable Labs, Ltd. | -9.77 Million USD | -9611.518% |
| Liquidia Corporation | -80.17 Million USD | -1084.142% |
| Mustang Bio, Inc. | -3.73 Million USD | -25312.152% |
| Immunovant, Inc. | -635.22 Million USD | -49.458% |
| Quantum-Si incorporated | -118.55 Million USD | -700.795% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -5305.363% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -22815.713% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 11927.557% |
| Acasti Pharma Inc. | -23 Million USD | -4026.92% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -28095.231% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -5742.675% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -589.268% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -30364.946% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -4170.412% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -5012.812% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -460.851% |
| PepGen Inc. | -60.67 Million USD | -1464.856% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -4032.129% |
| United Therapeutics Corporation | -507.7 Million USD | -87.0% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -4863.913% |
| Solid Biosciences Inc. | -47.75 Million USD | -1888.268% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -110027.609% |
| Immuneering Corporation | -54.94 Million USD | -1627.973% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -22485.957% |
| Silo Pharma, Inc. | -3.52 Million USD | -26838.565% |
| Belite Bio, Inc | -87.27 Million USD | -987.873% |
| XOMA Corporation | -29 Million USD | -3173.786% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -1242.911% |
| Bionomics Limited | 227 Million USD | 518.219% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -716.462% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -37381.169% |
| uniQure N.V. | -102.95 Million USD | -822.184% |
| Cassava Sciences, Inc. | -121.13 Million USD | -683.746% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -22692.328% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 2418.376% |
| Forte Biosciences, Inc. | -11.96 Million USD | -7837.447% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -30583.149% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 895758.491% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -29175.301% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 10761.404% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -12702.023% |
| Altimmune, Inc. | -134.48 Million USD | -605.94% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 579.337% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -37381.169% |
| Compugen Ltd. | -12.9 Million USD | -7257.393% |
| Peak Bio, Inc. | 10.34 Million USD | 9281.659% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -335376.325% |
| Benitec Biopharma Inc. | -50.58 Million USD | -1776.948% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -809.925% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 4932.772% |
| Zura Bio Limited | -99.8 Million USD | -851.243% |
| PolyPid Ltd. | 6.17 Million USD | 15487.326% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 1380.893% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 4932.772% |
| Instil Bio, Inc. | 75.35 Million USD | 1359.85% |
| argenx SE | -2.02 Billion USD | 53.205% |
| Immunome, Inc. | -97.02 Million USD | -878.468% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -4120.485% |
| Verona Pharma plc | -220.44 Million USD | -330.677% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -1223.332% |
| Shattuck Labs, Inc. | -121.42 Million USD | -681.887% |
| CervoMed Inc. | -7.79 Million USD | -12082.943% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -411.808% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -21610.45% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -620.66% |
| Moolec Science SA | 117.61 Thousand USD | 807301.401% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -41395.085% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 6071.665% |
| AnaptysBio, Inc. | -18.15 Million USD | -5130.555% |
| Design Therapeutics, Inc. | -18.15 Million USD | -5130.843% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -1248.941% |
| NeurAxis, Inc. | 145.7 Thousand USD | 651711.531% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 8552.618% |
| Lumos Pharma, Inc. | -28.49 Million USD | -3232.039% |
| Achilles Therapeutics plc | -126.92 Million USD | -648.005% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -1223.332% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -144684.896% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -4470.165% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 65210.789% |
| Nutriband Inc. | -251.65 Thousand USD | -377158.729% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -7108.245% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -12660.726% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 379.073% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 4099.992% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -112.17% |
| Palisade Bio, Inc. | -12.06 Million USD | -7770.331% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -576.638% |
| Beam Therapeutics Inc. | -262.72 Million USD | -261.37% |
| Neurogene Inc. | -131.95 Million USD | -619.486% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 4451.843% |
| AEON Biopharma, Inc. | -4.88 Million USD | -19354.877% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -151.702% |
| Sesen Bio, Inc. | -112.55 Million USD | -743.512% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -850.729% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -40337.892% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -2332.732% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -1039.98% |
| Athira Pharma, Inc. | -88.99 Million USD | -966.751% |
| Vaccinex, Inc. | -1.28 Million USD | -73611.025% |
| HCW Biologics Inc. | 2.85 Million USD | 33334.36% |
| XOMA Corporation | -29 Million USD | -3173.786% |
| Nektar Therapeutics | 210.24 Million USD | 551.578% |
| Arvinas, Inc. | -313.8 Million USD | -202.549% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 58600.453% |
| Merus N.V. | -192.88 Million USD | -392.212% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 1682.726% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -13584.03% |
| Rezolute, Inc. | -68.16 Million USD | -1292.733% |
| Clene Inc. | 3.34 Million USD | 28525.09% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -7099.5% |
| BeyondSpring Inc. | -13.75 Million USD | -6802.203% |
| Synlogic, Inc. | -6.68 Million USD | -14101.915% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 83821.164% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -11128.835% |
| Peak Bio, Inc. | 10.34 Million USD | 9281.659% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -1051.902% |
| Krystal Biotech, Inc. | -350.23 Million USD | -171.075% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 864.873% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -461.787% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -29971.419% |
| MannKind Corporation | 143.89 Million USD | 759.767% |
| Ikena Oncology, Inc. | -109.15 Million USD | -769.763% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -12439.929% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -2768.272% |
| Gossamer Bio, Inc. | 180.35 Million USD | 626.405% |
| CohBar, Inc. | -5.93 Million USD | -15908.111% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -3091.468% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 20892.773% |
| Mural Oncology plc | -255.84 Million USD | -271.086% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 3047.068% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -20054.323% |
| Disc Medicine, Inc. | -358.28 Million USD | -164.987% |
| Champions Oncology, Inc. | 4.81 Million USD | 19829.8% |
| REGENXBIO Inc. | 54.76 Million USD | 1833.49% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -352958.12% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -528.64% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -10434.813% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -1076.701% |
| Vaxart, Inc. | -8.24 Million USD | -11420.422% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -1791.986% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -646.584% |
| Cellectis S.A. | -43.85 Million USD | -2064.857% |
| Longeveron Inc. | -2.9 Million USD | -32547.799% |
| Repare Therapeutics Inc. | -107.85 Million USD | -780.23% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 198.04% |
| Inozyme Pharma, Inc. | 12 Million USD | 8009.014% |
| Revolution Medicines, Inc. | -608.2 Million USD | -56.099% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -77086.829% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -258.105% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -532.628% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -5967.604% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -128197.027% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 90.073% |
| Denali Therapeutics Inc. | -74.86 Million USD | -1168.147% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -7817.125% |
| Veru Inc. | 4.77 Million USD | 19962.012% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -8342.095% |
| Cingulate Inc. | 3.08 Million USD | 30897.782% |
| Passage Bio, Inc. | 4.58 Million USD | 20806.609% |
| Context Therapeutics Inc. | -14.44 Million USD | -6470.307% |
| Exicure, Inc. | 5.84 Million USD | 16331.8% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -312.108% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -2299.287% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 6150.59% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -1514.046% |
| Nuvalent, Inc. | -335.38 Million USD | -183.075% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 54841.138% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -1174.668% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -10579.393% |
| OmniAb, Inc. | 9.2 Million USD | 10416.18% |
| Anew Medical, Inc. | 1.43 Million USD | 66377.221% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 5895.46% |
| Lipocine Inc. | -4.75 Million USD | -19868.022% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -764.441% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 6333.327% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1774.095% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 3914.069% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -14025.844% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -1342.262% |
| Ocugen, Inc. | -32.52 Million USD | -2819.338% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -1009.434% |
| Q32 Bio Inc. | -37.94 Million USD | -2401.839% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -151078.025% |
| Alumis Inc. Common Stock | -13.52 Million USD | -6917.503% |
| Equillium, Inc. | -22.39 Million USD | -4139.898% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -3613.227% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -2809.874% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -382853.028% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 808.284% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 29787.242% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 289161.962% |
| Dominari Holdings Inc. | 195 Thousand USD | 486970.769% |
| Edesa Biotech, Inc. | -5.26 Million USD | -17925.711% |
| vTv Therapeutics Inc. | -8.91 Million USD | -10547.056% |
| Bio-Techne Corporation | 267.74 Million USD | 454.588% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -5757.227% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -703.934% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -11198.322% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -7404.529% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -287.321% |
| Nkarta, Inc. | 57.29 Million USD | 1756.919% |
| BioCardia, Inc. | 212 Thousand USD | 447929.245% |
| Iterum Therapeutics plc | 13.43 Million USD | 7165.025% |